PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 197 filers reported holding PACIRA PHARMACEUTICALS INC in Q2 2017. The put-call ratio across all filers is 0.70 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $12,000 | +50.0% | 240 | 0.0% | 0.00% | +50.0% |
| Q2 2018 | $8,000 | +14.3% | 240 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $7,000 | -36.4% | 240 | 0.0% | 0.00% | -33.3% |
| Q4 2017 | $11,000 | +22.2% | 240 | 0.0% | 0.00% | +50.0% |
| Q3 2017 | $9,000 | -18.2% | 240 | 0.0% | 0.00% | -33.3% |
| Q2 2017 | $11,000 | 0.0% | 240 | 0.0% | 0.00% | -25.0% |
| Q1 2017 | $11,000 | +37.5% | 240 | -4.0% | 0.00% | +33.3% |
| Q2 2016 | $8,000 | -38.5% | 250 | 0.0% | 0.00% | -50.0% |
| Q1 2016 | $13,000 | -31.6% | 250 | 0.0% | 0.01% | -40.0% |
| Q4 2015 | $19,000 | +90.0% | 250 | 0.0% | 0.01% | +66.7% |
| Q3 2015 | $10,000 | -44.4% | 250 | 0.0% | 0.01% | -40.0% |
| Q2 2015 | $18,000 | -18.2% | 250 | 0.0% | 0.01% | +66.7% |
| Q1 2015 | $22,000 | 0.0% | 250 | 0.0% | 0.01% | -50.0% |
| Q4 2014 | $22,000 | -8.3% | 250 | 0.0% | 0.01% | -20.0% |
| Q3 2014 | $24,000 | +4.3% | 250 | 0.0% | 0.02% | +7.1% |
| Q2 2014 | $23,000 | +35.3% | 250 | 0.0% | 0.01% | +27.3% |
| Q1 2014 | $17,000 | +21.4% | 250 | 0.0% | 0.01% | +10.0% |
| Q4 2013 | $14,000 | – | 250 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tamarack Advisers, LP | 360,000 | $21,845,000 | 6.19% |
| Gagnon Advisors, LLC | 213,217 | $12,938,000 | 4.92% |
| GAGNON SECURITIES LLC | 499,333 | $30,300,000 | 4.30% |
| Spyglass Capital Management LLC | 2,117,673 | $128,500,000 | 2.86% |
| NEUMEIER POMA INVESTMENT COUNSEL LLC | 646,530 | $39,231,000 | 2.30% |
| Paulson & Co. | 1,273,161 | $77,255,000 | 1.85% |
| MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 212,112 | $12,871,000 | 1.44% |
| Tygh Capital Management, Inc. | 152,332 | $9,244,000 | 1.26% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,147,000 | $69,600,000 | 1.24% |
| Rock Springs Capital Management LP | 1,025,000 | $62,197,000 | 1.23% |